Get In Touch

Kingsdale has protected and secured shareholder votes for more Canadian boards than any other firm. If you are a North American issuer, the time to engage us is before the situation demands it.

By providing your data, you agree to our Privacy Policy

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Subscribe to Our Newsletter

Article hero background
Insights
·
News

Wes Hall on What Boards Must Do Before the CUSMA Review

Kingsdale Advisors Founder and CEO Wes Hall is featured in the March/April 2026 edition of ICD's Director Journal, weighing in on one of the most consequential questions facing Canadian business leaders right now: what should boards be doing before the CUSMA review?

Wes, who sits on the Prime Minister's Council on Canada-U.S. Relations, is direct about where things stand. Free trade with the United States, as we have known it, is likely over. What comes next will be a trade agreement, but not a free one. For boards that have been operating on the assumption that North American trade will eventually return to normal, that distinction should be a wake-up call.

The article lays out a clear-eyed framework for directors navigating this shift. That means modelling downside scenarios beyond CUSMA, rethinking supply chains, and preparing for permanently higher tariffs not as a temporary disruption, but as the new baseline. The boards stress-testing these scenarios today will be far better positioned than those waiting to see how negotiations unfold.

As Wes puts it, “It has to be baked in now. We can't just hope and pray.”

The piece also addresses the broader structural challenge facing Canadian companies, including the urgent need to diversify trade relationships, reduce dependence on the U.S. market and build the kind of world-class businesses capable of competing globally. The message throughout is consistent: complacency is no longer an option.

Read the full article, “A Playbook for Tariffs and Uncertainty: What Directors Should Do Before the CUSMA Review,” in ICD’s Director Journal.

Directors looking for strategic advice to get ahead of what could be a very different trade landscape by year's end, please email strategy@kingsdaleadvisors.com.

Article side image

Latest Insights

Case Study

Case Study: Managing Closing Risk in the National Bank-CWB $5B M&A

National Bank’s acquisition of Canadian Western Bank required separate approvals from common shareholders, preferred shareholders, and LRCN holders, making transaction certainty a matter of precise execution.

2026
Read more
News
1.22.2026

Kingsdale Advisors Ranks #1 in Canada and Top 8 Globally: Bloomberg and LSEG

LSEG's newly published Global Shareholder Activism Review confirms Bloomberg's findings from earlier this month. Kingsdale Advisors ranks #1 in Canada and Top 8 globally for company-side proxy solicitation in FY 2025.

2026
Read more
News
1.20.2026

Podcast: Our EVP, Governance In Conversation With The Institute of Corporate Directors

Our EVP of Governance Advisory, Victor Li, joins ICD’s Rahul K. Bhardwaj on the "Be It Resolved" podcast to discuss J.P. Morgan’s shift from proxy advisors to proprietary AI. Leveraging decades of experience at Kingsdale and ISS, Victor analyzes if AI will displace industry giants and how directors must adapt their oversight.

2026
Read more
Business district aerial

When The Stakes Are Highest, Business Leaders Choose Kingsdale